Saurabh Saha, Chief Executive Officer at Centessa Pharmaceuticals plc (CNTA), sold 85,203 shares at $15.80 ($1.3M) on 2024-10-21, disclosed to the SEC on 2024-10-23.
Scheduled sale ($1.3M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.80 | 22,205 | $351K | 26.2% |
| 2 | $15.67 | 30,203 | $473K | 35.4% |
| 3 | $15.67 | 30,203 | $473K | 35.4% |
| 4 | $15.32 | 2,592 | $40K | 3.0% |
| Total | $15.69 avg | 85,203 | $1.3M | 100% |
| Filing → |
| CNTA | SELL | 2025-05-20 | $699K | — | Filing → |
| CNTA | SELL | 2025-04-22 | $1.4M | — | Filing → |
| CNTA | SELL | 2025-03-21 | $1.8M | — | Filing → |